Koda’s Fasting Therapy: Energy Balance and Intestinal Bacterial Flora

Crossmark: check for updates

Authors

  • Azusa Hirakawa Life Science Promoting Association, 25-3-1004, Daikyo-cho, Shinjuku, Tokyo 160-0015, Japan
  • Shaw Watanabe Life Science Promoting Association, 25-3-1004, Daikyo-cho, Shinjuku, Tokyo 160-0015, Japan
  • Shigeho Tanaka National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8636, Japan

DOI:

https://doi.org/10.17140/aftnsoj-1-120

Keywords:

Fasting therapy, Energy balance, Ketone bodies, β-hydroxy butyrate, Bifidobac-teriacae

Abstract

Since ancient times, fasting has been performed for religious reasons or as a cure of illnesses. Mitsuo Koda developed fasting dietary therapy and confirmed beneficial effects for many patients with intractable diseases. About 900-1000 kcal/day by unpolished brown rice, green vegetable paste and tofu constitute the basic regimen of Koda’s therapy. This case report deals with women patient (M) who had suffered spino-cerebellar degeneration at a young age and recovered by using Koda’s method. She had been living on only one glass of fresh veg-etable juice per day for 19 years since her acute episode at age 20. Four other persons who were experimenting Koda’s method were asked to join the study for comparison. In our case series, the Basic Metabolic Rate (BMR) was 1000-1200 kcal, which was equivalent with the intake, but in case of M the nutritional intake was almost one tenth of others. M’s ketone bodies, especially β-Hydoxy Butyrate (BHB) in the blood, were more than 3 mM, so the main energy should come from ketone bodies. Biochemical changes of M coincided with the metabolic adaptation to yield BHB, as shown by elevated Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and Creatine Kinase (CK). High aspartate was a reflection of above metabolic change. Increased BHB was observed in two participants, M and H, and both of them had Bifidobacteriacae in fecal bacteria. Energy balance and biochemical changes were discussed in these five subjects with calorie restriction.

References

Hideo T. Study on fasting, Iwanami Book Pub, Tokyo, 1999

Cahill GF Jr. Starvation in man. New Engl J Med. 1970; 282: 668-675. doi: 10.1056/NEJM197003192821209

Watanabe S. Japanese longevitgy and dietary life. Mituso Koda. Clin & Funct Nutriol. 2012; 4: 148-150

Mitsuo Koda. Science of fasting therapy. 3rd ed. Shinju-sha, Tokyo, 2000

Watanabe S, Zhuo XG, Kimira M. Food safety and epidemiology: new database of functional food factors. BioFactors. 2004; 22: 213-219. doi: 10.1002/biof.5520220144

Matsuda M, Mori M, Watanabe S. Successful dietary therapy beyond ordinary nutritional science. Clin & Funct Nutr. 2012; 4: 118-126

Ebios. Available at: http://www.asahi-fh.com/ebios/product/ ebios.html 2015; Accessed 2015

Spirulina. Available at: http://www.spirulina.co.jp/spirulina/ eiyouseibun.html 2015; Accessed 2015

Suimag. Available at: http://www.mihoseiyaku.co.jp/suimag/ 2015; Accessed 2015

Tanaka S, Ohkawara K, Ishikawa-Takata K, Morita A, Watanabe S. Accuracy or predictive equations for basal metablic rate and contribution of abdominal fat distribution to basal metabolic rate in obese Japanese people. Anti-Aging Med. 2008; 5: 17-21. doi: 10.3793/jaam.5.17

Weir JB. New methods for calculating metabolic rate with Journal special reference to protein metabolism. J Physiol. 1949; 109: 1-9

Watanabe S, Noboru M, Yasunari M, Ideura T. A cross-sectional study of the effects of long term very low protein diets in patient with chronic kidney disease: serum and urine, DEXA and aminoacid profiles. Anti Aging Med. 2010; 7: 7-13

Matsuki T, Watanabe K, Fujimoto J, et al. Quantitative PCR with 16S rRNA-gene-targeted species-spcific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004; 70: 167-173. doi: 10.1128/AEM.70.1.167-173.2004

Nakayama J, Jian J, Watanabe K, et al. Up to species-level community analysis of human gut microbiota by 16S rRNA amplicon pyrosequencing. Biosci Microbiota Food Heal. 2013; 32: 69-76. doi: 10.12938/bmfh.32.69

Kurakawa T, Ogata K, Matsuda K, et al. Diversity of intestinal clostridium coccoides group in the Japanese population, as demonstrated by reverse transcription-quantitative PCR. PLOS One. 2015. doi: 10.1371/journal.pone.0126226

Watanabe S. Reevaluation of Koda’s fasting therapy for rheumatic diseases. In: Nanakawa K, ed. Rheumatic disease seminar 25. Nagai-shoten, Osaka, 2014: 125-134

Dietary Reference Intakes for Japanese-2010. The summary report from the Scientific Committee of Dietary Reference intakes for Japanese. http://www0.nih.go.jp/eiken/info/pdf/dris- 2010en.pdf 2010; Accessed 2015

Osame M. Hormonal change during 3 day starvation with/ without glucose loading test. Clinical & Functional Nutriol. 2010; 2: 331-335

Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999; 15(6): 412-426. doi: 10.1002/(SICI)1520-7560( 199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8

Cahill Jr. GF. Fuel metabolism in starvation. Ann Rev Nutr. 2006; 26: 1-22. doi: 10.1146/annurev.nutr.26.061505.111258

Cahill GF, Veechi RL. Ketoacids? Good medicine? Transactions of the American Clinical and Climatological Association. 2003; 114: 149-163

Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, et al. Medical aspects of ketone body metabolism. Clin Invest Med. 1995; 18: 193-216

Goldblatt MW. Observations on the effect of various carbohydrates on the ketosis of starvation in human subjects. Biochem Open Journal J. 1925; 19: 948-958

Keys A. The biology of human starvation. In: Keys A, Bronzed J, Menschel A, Michelsen O. Taylor HL, eds. University of Minessota Press, Menneapolis, 1950: 2

Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969; 48: 574-583. doi: 10.1172/JCI106016

Saudek CD, Felig P. The metabolic events of starvation. Am J Med. 1974; 60: 117-126

Chiu RW, Ho CS, Tong SF, Ng KF, Lam CW. Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration. Hong Kong Med J. 2002; 8: 172-176

Hayashi H, Sakamoto M, Bennno Y. Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol. 2002; 46: 819-831

Noack-Loebel C, Kuster E, Rusch V, Zimmermann K. Influence of different dietary regimen upon the composition of the human fecal flora. Prog Food Nutr Sci. 1983; 7: 127-131

Finegold SM, Sutter VI, Mathisen GE. Normal indigenous flora. In: Hentges DJ, ed. Human intestinal microflora in health and disease. Academic Press, New York, 1983: 3-31. Available at: http://www.mihoseiyaku.co.jp

Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota. Diabetes Care. 2010; 33: 2277-2284. doi: 10.2337/dc10-0556

Zoetendal EG, Vaughan EE, deVos WM. A microbial world within us. Mol Microbiol. 2006; 59: 1639-1650. doi: 10.1111/j.1365-2958.2006.05056.x

Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023. doi: 10.1038/4441022a

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027- 1031. doi: 10.1038/nature05414

Watanabe S. Beyond the science-biovitalism. Kiragenne, Tokyo, 2015

Published

2015-11-23

How to Cite

Azusa Hirakawa, Shaw Watanabe, & Shigeho Tanaka. (2015). Koda’s Fasting Therapy: Energy Balance and Intestinal Bacterial Flora. Advances in Food Technology and Nutrition Sciences, 1(5), 112–123. https://doi.org/10.17140/aftnsoj-1-120